1,235 followers
A study from the @yonsei_u College of Medicine suggests #CRS did not predict survival for BRCA 1/2 mutation carriers. So, BRCA status should or should not be considered for deciding about #PDS vs #NACT in #ovariancancer ? https://t.co/JgKSmhY3GO @TeamOvary